PCI Biotech Holding ASA (DE:4QG) has released an update.
PCI Biotech has announced the awarding of 885,000 share options to key employees, with a three-year vesting term and a strike price of NOK 1.81. Among the recipients, CEO/CFO Ronny Skuggedal received 400,000 options, increasing his total unexercised options to 1,020,000. The long-term incentive plan aims to encourage executives to maintain a significant level of company share ownership.
For further insights into DE:4QG stock, check out TipRanks’ Stock Analysis page.
